e-learning resources

ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

What is new in COPD management and prognosis: findings from large studies?

Poster Discussion
Chairs: L. Fregonese (London, United Kingdom), N. Kahn (Heidelberg, Germany)

Download all media

Download all media

Clinical effect of different pneumococcal vaccination schedules in patients with chronic obstructive pulmonary disease (COPD): long-term follow-up results A. Protasov (Samara, Russian Federation)
Impact of comorbid bronchiectasis on COPD patients A. Ben Saad (Monastir, Tunisia)
Population-based analysis of COPD patients in Catalonia: implications for case management E. Baltaxe (Barcelona, Spain)
Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients C. Chen (Tainan, Taiwan)
Determining SGRQ and TDI responder rates across the duration of clinical trials: Results from tiotropium + olodaterol in COPD E. Derom (Ghent, Belgium)
Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD E. Crisafulli (Pavullo (MO), Italy)
Evaluation of roflumilast in COPD patients in a real-world European setting: results from the PROFILE EU study C. Vogelmeier (Marburg, Germany)
MISSION COPD: A novel model of integrated multidisciplinary COPD care that demonstrates significant reductions in unscheduled health care usage. E. Lanning (Winchester, United Kingdom)
Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD F. Martinez (New York, United States of America)
Carbon monoxide transfer factor (DL,CO), age and gender add to the BODE index to predict survival in COPD patients E. Marchand (Yvoir, Belgium)
Use of the Daily PROactive instrument to evaluate physical activity in patients with COPD: results from ACTIVATE J. Garcia Aymerich (Barcelona, Spain)
High CAT score predicts lung parenchymal damage in COPD A. Lindqvist (Helsinki, Finland)
A real world experience of COPD exacerbations and possible association with Bronchiectasis in a medium size teaching hospital in the northwest of England H. Singh (Preston, United Kingdom)
Elevated systemic biomarkers and persistent anxiety and depression in smokers with and without COPD: An analysis of the SPIROMICS cohort V. Kim (Philadelphia, United States of America)
Using Gold Standard Framework Criteria in COPD: Empowering Patients to make Choices about End of Life Care S. Gudur (Preston, United Kingdom)
Mortality after an acute exacerbation of COPD (AECOPD): findings from the National COPD Audit Programme J. Holzhauer-Barrie (London, United Kingdom)
What predicts a deterioration of generic and disease-specific health-related quality of life in COPD? First longitudinal results of the COSYCONET cohort M. Wacker (Neuherberg, Germany)

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.